Skip to main content
Clinical Trials/NCT04782921
NCT04782921CompletedNot Applicable

Clinical Outcomes of Papillae Tunneling Techniques in the Treatment of Isolated Intrabony Defects - a Prospective, Double Blind, Randomised Clinical Trial

University of Ljubljana2 sites in 1 country20 target enrollmentStarted: March 3, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
20
Locations
2
Primary Endpoint
Clinical attachment level change (CALC)

Study Overview

Brief Summary

Papillae tunneling techniques (PTT) are a new approach toward regeneration of isolated intrabony defects. Compared to regular papillae preservation techniques, PTT rely on complete preservation of involved interdental papillae, providing optimal healing environment for periodontal wound. Surgical access is therefore gained either by vertical incision in vestibulum, or by short releasing incision on adjacent tooth. Interdental tissue is then carefully raised in a full thickness manner by tunneling instruments, root surface thoroughly cleaned by the ultrasound scaler or Gracey curettes and defect filled with the biomaterial of choice.

While the success and aesthetic results of non-incised papillae techniques are well documented, no paper so far compared clinical results of papillae preservation techniques with different biomaterials.

Therefore, the aim of our study is to compare gain of clinical attachment level (defined by sum of pocket probing depth and recession) to regular papillae preservation techniques, and to prove non-inferiority of Gel 40® (collagen matrix, loaded with micronized heterologous bone) to Gen-Os® (granulated cortico-cancellous heterologous bone mix).

Secondary objectives include analysis of aesthetic parameters - differences in recession and tip of the papillae location before and after the treatment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •periodontitis stage III/IV
  • •at least one periodontal lesion with pocket probing depth > 5 mm, limited by 2 or more bone walls and intrabony component > 3 mm.
  • •good oral hygiene with plaque index and sulcular bleeding index < 30%.
  • •systemically healthy
  • •smokers and non-smokers

Exclusion Criteria

  • •systemic diseases that contraindicate the treatment,
  • •on medications that affects periodontal healing
  • •pregnant or lactating women
  • •one wall intrabony defects
  • •defects that involve buccal and lingual side of the tooth
  • •tooth with incorrect endodontic treatment or restoration

Arms & Interventions

Gel 40

Experimental

Application of Gel 40

Intervention: Xenogenic bone graft material (Device)

Gen-Os

Active Comparator

Application of Gen-Os

Intervention: Xenogenic bone graft material (Device)

Outcomes

Primary Outcomes

Clinical attachment level change (CALC)

Time Frame: 6 and 12 months

To evaluate the clinical attachment level change (CALG) in reconstructive periodontal treatment of isolated intrabony defects, using papillae preservation techniques and different biomaterials (Gel 40®, Gen-Os®).

Secondary Outcomes

  • Wound closure (WC)(1 week)
  • Tip of papillae(6 and 12 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials